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Abstract 16 
Sugar esters are biodegradable, nonionic surfactants which have microbial inhibitory properties.  17 
The influence of the fatty acid chain length on the microbial inhibitory properties of lactose 18 
esters was investigated in this study.  Specifically, lactose monooctanoate (LMO), lactose 19 
monodecanoate (LMD), lactose monolaurate (LML) and lactose monomyristate (LMM) were 20 
synthesized and dissolved in both dimethyl sulfoxide (DMSO) and ethanol.  Minimum inhibitory 21 
concentrations (MIC) and minimum bactericidal concentrations (MBC) were determined in 22 
growth media.  LML was the most effective ester, exhibiting MIC values of <0.05 to <5 mg/ml 23 
for each Gram-positive bacteria tested (Bacillus cereus, Mycobacterium KMS, Streptococcus suis, 24 
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Listeria monocytogenes, Enterococcus faecalis, and Streptococcus mutans) and MBC values of 25 
<3.0 to <5 mg/ml for B. cereus, M. KMS, S. suis, and L. monocytogenes.  LMD showed MIC and 26 
MBC values of <1 to <5 mg/ml for B. cereus, M. KMS, S. suis, L. monocytogenes, and E. 27 
faecalis, with greater inhibition when dissolved in ethanol.  LMM showed MIC and MBC values 28 
of <1 to <5 mg/ml for B. cereus, M. KMS, and S. suis.  LMO was the least effective showing a 29 
MBC value of <5 mg/ml for only B. cereus, though MIC values for S. suis and L. monocytogenes 30 
were observed when dissolved in DMSO.  B cereus and S. suis were the most susceptible to the 31 
lactose esters tested, while S. mutans and E. faecalis were the most resilient and no esters were 32 
effective on Escherichia coli O157:H7.  This research showed that lactose esters esterified with 33 
decanoic and lauric acids exhibited greater microbial inhibitory properties than lactose esters of 34 
octanoate and myristate against Gram-positive bacteria.  35 
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1. Introduction 43 
Sugar esters are nonionic surfactants used in a variety of applications in the food, 44 
pharmaceutical, and personal care industries.  The microbial inhibitory activity of sugar esters 45 
has been studied.  Although it has been shown that sugar esters inhibit bacterial growth, there is a 46 
lack of consensus as to which bacteria are most susceptible. While some studies have shown 47 
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inhibitory effects of Gram-negative bacteria (Ferrer et al., 2005; Habulin et al., 2008; Zhang et 48 
al., 2014; Smith et al., 2008), others have shown inhibition of only Gram-positive bacteria 49 
(Wagh et al. 2012; Piao et al. 2006). Studies have shown that esters containing laurate were 50 
inhibitory against both Gram-positive and Gram-negative bacteria (Smith et al., 2008; Nobmann 51 
et al., 2009; Zhang et al., 2014).  A study on the microbial inhibitory activity of lactose 52 
monolaurate showed low minimum inhibitory concentrations (MIC) and minimum bactericidal 53 
concentrations (MBC) for Listeria monocytogenes and Mycobacterium sp. strain KMS, and no 54 
inhibitory activity against Gram-negative bacteria (Wagh et al., 2012).  55 
The nature and number of fatty acid chains esterified to sugars can be variable, yielding a 56 
broad range of hydrophilic-lipophilic balances and microbial inhibitory activities (Szuts et al. 57 
2012).  Previous research showed that fatty acid derivatives such as monolaurin are highly 58 
inhibitory and more inhibitory than lauric acid (Smith et al., 2008; Nobmann et al., 2009).   59 
Others have reported that sugar monoesters of decanoic, myristic and palmitic acids were 60 
microbial inhibitory (Piao et al., 2006; Habulin et al., 2008; Zhang et al., 2014). There was one 61 
study investigating the microbial inhibition of sugar octanoate esters which showed no inhibitory 62 
effects (Zhang et al., 2014). 63 
Of the carbohydrate fatty acid esters previously investigated, sucrose esters have been the 64 
most thoroughly studied (Nobmann et al., 2009).  Other oligosaccharide esters of laurate, 65 
including maltose, fructose and galactose have been synthesized and have generally been shown 66 
to be very effective microbial inhibitory agents (Nobeman et al., 2009; Watanabe et al., 2000; 67 
Devulapalle et al., 2004; Habulin et al., 2008), whereas hexose laurate did not suppress microbial 68 
growth significantly (Watanabe et al., 2000).   69 
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While many studies examine the microbial inhibition of sugar esters in terms of MIC 70 
values, few studies have determined the MBC values of sugar esters. In this study we 71 
synthesized novel lactose esters including lactose monooctanoate (LMO), lactose 72 
monodecanoate (LMD) and lactose monomyristate (LMM).  The microbial inhibitory properties 73 
of these esters (MIC and MBC) in microbial growth media, and the previously synthesized ester, 74 
lactose monolaurate (LML) (Wagh et al., 2012) were determined against Gram-positive (Bacillus 75 
cereus, Mycobacterium KMS, Streptococcus suis, Listeria monocytogenes, Enterococcus faecalis 76 
and Streptococcus mutans) bacteria and the Gram-negative bacteria, Escherichia coli O157:H7. 77 
Furthermore, we also determined the MIC and MBC values of the esters dissolved in two 78 
solvents, DMSO and ethanol. This allowed us to ascertain the role of the solvents in the 79 
microbial inhibitory activity.  80 
 81 
2. Materials and Methods 82 
2.1 Bacterial strains 83 
Bacterial strains used are listed in Table 1.  E. faecalis V538 and L. monocytogenes 84 
EGDe were received from Dr. Andy Benson of the University of Nebraska, Lincoln. Different 85 
clinical isolates of Listeria (FSL J1-177, FSL N3-013, FSL R2-499 and FSL N1-227) were 86 
obtained from Dr. Martin Wiedmann, director of the international Life Sciences Institute North 87 
American Database at Cornell University.  S. suis 89/1591 was received from Dr. Richard 88 
Higgins of University of Montreal, Qubec, Canada.  M. KMS was isolated by Utah State 89 
University from treatment soils in Champion International Superfund Site, Libby, Montana. B. 90 
cereus ATCC 13061, S. mutans ATCC 25175 and E. coli O157:H7 EDL 931 stains were 91 
obtained from ATCC (Manassas, VA).  92 
 93 
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2.1 Materials and equipment 94 
Materials and equipment included a high-performance liquid chromatography (HPLC) 95 
(Beckman System Gold 125 Solvent Module, Onterio, Canada) equipped with Luna 5m C18 96 
100Å (250 mm x 4.6 mm, Phenomenex, Torrance, CA, USA) and an evaporative light scattering 97 
detector (Agilent Technologies, Santa Clara, CA USA), incubator shaker, spectrophotometer 98 
(Beckman, USA), 48 microtitre well plates (Becton Diskinson, NJ, USA), brain-heart infusion 99 
(BHI) media, Lauria-Bertani (LB) media, granulated agar (BD, New Jersey, USA), lactose 100 
(Proliant, Iowa, USA), vinyl laurate, vinyl myristate, vinyl decanoate, vinyl octanoate (TCI, 101 
Portland OR, USA), lipase TM2 (immobilized from Thermomyces lanuginose), Tween 80, 102 
Whatman glass microfiber filters, molecular sieves (3A), 2-methyl-2-butanol (2M2B) (dried 103 
using 10% 3A molecular sieves), dimethyl sulfoxide (DMSO)  (Sigma Aldrich, MO, USA), 104 
ethanol, and acetonitrile (HPLC grade, Thermo Fisher, PA, USA). 105 
 106 
2.2 Lactose ester synthesis and purification 107 
Enzymatic synthesis of LML was performed according to Walsh et al., (2009). Synthesis 108 
of LMO was conducted using lactose, vinyl octanoate, molecular sieves and immobilized lipase 109 
enzyme TM2.  For a 60 mL reaction in 2M2B, 3 g of lactose, 6 g of dried molecular sieves, 1.7 110 
mL of vinyl octanoate (lactose to fatty acid ratio of 1: 2.1) and 1.8 g TM2 were combined. The 111 
reactions were assembled in a 100 mL glass bottle and incubated at 60°C and 90 rpm for 2 days. 112 
The amount of LMO synthesized was determined using HPLC with the evaporative light 113 
scattering detector set at 60°C with a nitrogen gas pressure of 3.55 bar. There was a gradient 114 
from 10% acetonitrile-water (40:60, v/v) to 100% acetonitrile-water (95:5, v/v) as the mobile 115 
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phase.  Synthesis of LMM and LMD was done as described above for LMO using the same 116 
molar ratios of lactose to fatty acid (vinyl myristate or vinyl decanoate). 117 
For ester purification, the 2M2B reaction was filtered through a Whatman glass 118 
microfiber filter then dried in a hood for 24 h. The dry solids were suspended in 60 % ethanol, 119 
40% water (60 ℃) and placed in a separatory funnel. The lower aqueous layer was drained into a 120 
beaker and dried in a hood for 24 h. After completely drying, the product powder was suspended 121 
in acetone, and then centrifuged for 15 min at room temperature at 2,000 x g and the supernatant 122 
analyzed via HPLC for the presence of di- tri- or higher saccharides. The acetone extraction was 123 
repeated until only the monoester was present in the pellet. 124 
 125 
2.3 Microbial inhibitory studies 126 
Stock solutions of LMO (60 mg/ml) and LMD (25 mg/ml) were prepared in 30% 127 
ethanol:water. Stock solutions of LML (60 mg/ml) were prepared in 50% ethanol:water and 128 
100% DMSO.  Stock solutions of LMO and LMD (60 mg/ml) were prepared in 100% DMSO.  129 
LMM was not soluble in 60% ethanol:water hence a stock (60 mg/ml) was prepared in 100% 130 
DMSO. Controls were 30% ethanol:water, 50% ethanol:water and 100% DMSO. Ester stock 131 
solutions were diluted into growth media to give final ethanol concentrations ranging from 0.5 to 132 
10% and final DMSO concentrations ranging from 2 to 8%. All seven stocks of esters and 133 
controls were tested on the bacteria listed in Table 1. 134 
Analysis of microbial inhibitory activities of LMO was performed by making a 5 strain 135 
cocktail of L. monocytogenes including C1-056, J1-177, N1-277, N3-013, and R2-499. The 136 
individual 5 stocks were stored at -80℃, and each individual freezer stock (20 µl) was added to 137 
15 ml of BHI media. The Listeria strains were grown at 37 ℃ and 200 rpm for 24 h. Aliquots (2 138 
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ml) from each strain were combined in a test tube to develop the 5-strain stock cocktail.  139 
Aliquots, 315 µl, of the stock cocktail were grown in BHI media (12 ml), and incubated with 140 
shaking at 37 ℃ for 4 h. Aliquots of the 5-strain stock cocktail were kept at -80°C.  141 
Stock solutions of the other bacteria were maintained at -80 ℃ before use.  Aliquots of 142 
bacterial stock solutions (300 µl) were grown in 15 ml media at 37 ℃, 200 rpm for 24 h.  143 
Aliquots of the overnight growths (300 µl) were added to 12 ml media and grown again at 37 ℃, 144 
200 rpm for 4 h before use. The growing cultures were monitored by optical density 145 
measurements at 660 nm (OD600) and diluted with fresh media to reach an OD600 of 0.2 which 146 
was approximately 1 x 108 cfu/ml.  An aliquot of the culture, 100 µl, was mixed with 10 ml fresh 147 
media containing 0.1% Tween 80. The ester stock ester solutions were added to each well for 148 
final concentrations of 0.05, 0.1, 0.5, 1, 3, and/or 5 mg/ml and each well contained a total of 0.5 149 
ml. Controls contained the same concentration of ethanol or DMSO as the treatments.  Each 150 
treatment and control was performed in triplicate and replicated three times. A paired T- test was 151 
used to compare the treatments with the controls at each concentration to determine if the 152 
treatments were significantly different from the controls.  All controls and treatments were plated 153 
on appropriate agar and incubated at 37°C for 24 hrs to obtain plate counts. The MIC of each 154 
compound was determined as the lowest concentration which showed a significant difference in 155 
the number of cells in treatments as compared to those in controls as determined by plate counts. 156 
Similarly, the MBC of each compound for each organism was reported as the minimum 157 
concentration of ester at which there was no cell growth as determined by plate counts. 158 
 159 
3. Results 160 
3.1 Minimum inhibitory concentrations (MIC) of lactose esters 161 
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In our earlier work, we showed that the novel lactose ester, LML (in 50% ethanol:water) 162 
was antimicrobial towards L. monocytogenes and M. KMS, but had no activity against Gram-163 
negative bacteria (Wagh et al., 2012).  In this study, additional lactose esters, LMO, LMD, and 164 
LMM were synthesized, and along with LML, were dissolved in both ethanol and DMSO, and 165 
tested for microbial inhibitory activity against Gram-positive bacteria and E. coli O157:H7. The 166 
control samples contained the same concentration of solvent as the treatments. 167 
 The MIC values of the lactose esters against various Gram-positive bacteria are listed in 168 
Table 2.  LML was found to be the most effective microbial inhibitory ester since it showed MIC 169 
values (<0.05 to <5 mg/ml) for each Gram-positive bacteria tested in each solvent. On average, 170 
there were lower MIC values with LML/ETOH for M. KMS, L. monocytogenes and E. faecalis. 171 
The MIC for LML/DMSO with E. faecalis was 5 mg/ml, which was the highest MIC value for 172 
LML among the bacteria tested.  173 
The MIC values of LMD/DMSO ranged from <1 to <3 mg/ml for B. cereus, M. KMS and 174 
S. suis. The MIC for LMD/DMSO for L. monocytogenes, E. faecalis and S. mutans was above 5 175 
mg/ml. The MIC values for LMD/ETOH ranged from <3 to <5 mg/ml with no MIC values for S. 176 
mutans.  Ethanol itself was inhibitory, specifically with M. KMS which showed no cells in the 177 
control or treatment with 5 mg/ml LMD/ETOH (corresponding to 10% ethanol), therefore, no 178 
MIC could be determined.  LMD/ETOH inhibited the growth of L. monocytogenes and E. 179 
faecalis while LMD/DMSO showed no inhibitory effects on these bacteria.  180 
LMM in DMSO showed inhibitory activity against B. cereus, M. KMS and S. suis with 181 
MIC values between <1 mg/ml and <5 mg/ml. However, the MIC values for LMM with L. 182 
monocytogenes, E. faecalis and S. mutans were >5 mg/ml.  183 
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LMO/ETOH showed no inhibitory effect at concentrations up to 5 mg/ml but 184 
LMO/DMSO was inhibitory to B. cereus, S. suis and L. monocytogenes.  S. suis and L. 185 
monocytogenes were more sensitive with MIC values <3 mg/ml than B. cereus with an MIC 186 
value <5 mg/ml. No ester dissolved in either DMSO or ethanol showed microbial inhibitory 187 
activity against the Gram-negative bacteria tested (E. coli O157:H7). 188 
 189 
3.2 Minimum bactericidal concentrations (MBC) of lactose esters 190 
 The MBC of the lactose esters are reported in Table 3 as well as the log reductions in the 191 
treatments as compared to the controls.  No esters showed bactericidal activity against S. mutans.  192 
Out of the 4 compounds tested, LML was the only lactose ester to exert a bactericidal effect 193 
against B. cereus, M. KMS, S. suis and L. monocytogenes in both solvents used. The MBC values 194 
of LML/DMSO were <1 mg/ml for B. cereus, M. KMS, and S. suis.  MBC concentrations of 195 
LML were lower in DMSO compared to ethanol for B. cereus and S. suis. 196 
In tests against the Gram-positive bacteria, LMD/ETOH showed broad antimicrobial 197 
activity against B. cereus, S. suis and L. monocytogenens and E. faecalis with MBC values  198 
between <3 mg/ml and <5 mg/ml. However, LMD/DMSO was not shown to be bactericidal to L. 199 
monocytogenes or E. faecalis at concentrations up to 5 mg/ml. Furthermore, bactericidal activity 200 
of ethanol was shown against M. KMS, with no cells growing in the control or treatment at 10% 201 
ethanol as stated earlier for the MIC values. LMM/DMSO was effective against B. cereus, M. 202 
KMS and S. suis with MBC values between <3 and <5 mg/ml.  203 
 LMO/ETOH showed no bactericidal effects up to concentrations of 5 mg/ml whereas 204 
LMO/DMSO was only shown to have bactericidal activity against B. cereus at <5 mg/ml. 205 
DMSO was itself inhibitory towards S. suis with no growth in the treatment of controls with 206 
 10 
LMO/DMSO containing 8% DMSO, therefore no MBC could be determined.   S. mutans and E. 207 
faecalis were observed to be the most resilient among the bacteria tested and B. cereus was the 208 
most susceptible.  Only LMD/ETOH was observed to be bactericidal against E. faecalis.  209 
 210 
4. Discussion 211 
Carbohydrate fatty acid derivatives are biodegradable, nontoxic and non-skin irritant 212 
surfactants with microbial inhibitory activity (Szuts et al., 2012). The microbial inhibitory 213 
properties of these derivatives are increasingly of interest and many of these compounds have 214 
been shown to inhibit Gram-positive rather than Gram-negative bacteria (Piao et al., 2006; Wagh 215 
et al., 2012). This study evaluated both microbial inhibitory and bactericidal properties of lactose 216 
esters. LML was shown to be the most effective lactose ester in preventing microbial growth, 217 
yielding the lowest MIC values in the range of <0.05 mg/ml to <5 mg/ml (0.095 mM to <9.53 218 
mM) against each Gram-positive bacteria tested.  Moreover B. cereus and S. suis appeared to be 219 
the most susceptible with MIC values obtained for each ester tested, and the lowest MIC value 220 
was obtained with LML/ETOH and M. KMS (<0.05 mg/ml or <0.095 mM).  With regards to 221 
previous studies of bacterial inhibition with lactose esters, LML/ETOH showed inhibitory 222 
activity against L. monocytogenes at concentrations of 0.1 mg/ml (0.19 mM) (Wagh et al., 2012). 223 
Similar microbial inhibitory effects of LML were observed in another study in which 224 
LML/ETOH inhibited the growth of L. monocytogenes in milk, low fat yogurt and cheese at <5 225 
mg/ml (Chen et al. 2013). 226 
It is known that the identity of the sugar group attached to the ester plays a role in 227 
modulating the antimicrobial activity [3, 7]. The antimicrobial effect of sugar esters has 228 
traditionally be measured and reported as MIC values, with no MBC values given. Smith et al., 229 
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(2008) and Nobmann et al., (2009) reported MIC values in the range of 0.04 mM to 0.31 mM for 230 
lauric methyl D-glucopyranoside and lauric ester of methyl α-D-mannopyranoside with S. aureus 231 
and Listeria strains. Watanabe et al. (2000) also showed inactivation of S. mutans by both 232 
galactose laurate and fructose laurate, with MIC values of 0.05 mg/ml and 0.2 mg/ml 233 
respectively, whereas hexose laurate did not suppress microbial growth.  In a similar study, 234 
inhibitory effects of the sugar esters 6'-O-lauroylmaltose, 6'-O-lauroylsucrose, and 6"-O-235 
lauroylmaltotriose were observed against Streptococcus sobrinus, with MIC values of 0.1 mg/ml 236 
(Devulapalle et al., 2004). Therefore, laurate sugar esters have previously been shown to be 237 
microbial inhibitory against Gram-positive bacteria. 238 
The importance of the fatty acid was investigated in this study using octanoatic, decanoic, 239 
lauric, and myristic acids esterified to lactose. LMM and LMD were effective in controlling the 240 
growth of B. cereus, M. KMS and S. suis.  Previous research showed that erythritol and xylitol 241 
monomyristoyl suppressed Bacillus growth with MIC values between 6.3 g/ml and 12.5 g/ml 242 
(Piao et al., 2006), which are lower than reported here. As for short chain esters, Zhang et al., 243 
(2014) reported that sucrose and glucose octanoate had no inhibitory effect against S. aureus and 244 
E.coli H7:O157.  In contrast, we showed LMO/DMSO to have microbial inhibitory activity 245 
against B. cereus, S. suis and L. monocytogenes with MIC values ranging from 3 mg/ml to 5 246 
mg/ml respectively.   247 
Zhang et al., (2014) reported that sucrose and glucose monodecanoate showed inhibitory 248 
effects against S. aureus at 4 mg/ml and 3 mg/ml, respectively. In a similar study, Smith et al., 249 
(2008) and Nobman et al., (2009) reported that a glucose fatty acid ether containing decanoic 250 
acid showed the greatest activity against S. aureus and Listeria at concentrations of 0.04 mM but 251 
was effective against E. coli at 20 mM.  In this study, we showed that LMD had MIC values for 252 
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all bacteria tested except S. mutans, although the MIC values were solvent dependent for M. 253 
KMS, L. monocytogenes and E. faecalis. 254 
Our previous research (Wagh et al., 2012) showed that LML was not inhibitory to the 255 
Gram-negative bacteria, E. coli O157:H7, Salmonella enterica or Klebsiella pneumonia and this 256 
study showed that the other esters (LMO, LMD and LMM) were not inhibitory to E. coli 257 
O157:H7 (data not shown). On the other hand, there are a limited number of studies showing 258 
microbial inhibitory properties of sugar esters against Gram-negative bacteria. Ferrer et al., 259 
(2005) and Habulin et al., (2008) both reported limited inhibition of E. coli by sucrose 260 
monolaurate with MIC values of 4 mg/ml and 6.25 mg/ml respectively. Zhang et al., 2014) 261 
showed that methyl α-D-glucopyranoside monolaurate was effective in inhibiting the growth of 262 
both S. aureus and E. coli O157:H7 at a concentration of 0.188 mg/ml.  263 
 Compared to the amount of literature on the microbial inhibitory properties of sugar 264 
esters, there is very little information about the effects of the solvent used. Previous studies on 265 
microbial inhibitory activities of sugar esters involved dissolving sugar esters into an ethanol 266 
solution (Smith et al., 2008; Nobmann et al., 2009; Wagh et al., 2012; Chen et al., 2013) or 267 
DMSO (Ferrier et al., 2005) before diluting into growth media.  Others have added esters directly 268 
into growth media (Devulapalle et al., 2004; Piao et al., 2006).  All of the esters used in the 269 
current study were soluble in a 50% ethanol solution except LMM; therefore, we only tested 270 
LMM in DMSO.  Previous studies with LML showed that final ethanol concentrations greater 271 
then 7.5% were microbial inhibitory towards L. monocytogenes (Chen et al., 2013).  In this study 272 
we found that 10% ethanol was antimicrobial to M. KMS and 8% DMSO was 273 
antimicrobial/inhibitory to S. suis. The effect of the solvent on the cell growth can be observed 274 
by the log reductions in Table 3, specifically for S. suis with LMM/DMSO and LMO/DMSO.  275 
 13 
 In general, the MIC values of the LML/ETOH treatments were lower than the 276 
LML/DMSO treatments suggesting compounding stress of both LML and ethanol lead to growth 277 
inhibition as suggested by Chen et al., (2013). Similar results are seen with LMD/ETOH, where 278 
MIC values were obtained for L. monocytogenes and E. faecalis, but not with LMD/DMSO.  279 
Conversely, the MBC values of LML/DMSO were lower or equal to the LML/ETOH values. 280 
Therefore, the effect of ethanol on the MBC values is not understood. 281 
 282 
5. Conclusions 283 
 The results suggest that the chain length of the fatty acid ester significantly influences the 284 
microbial inhibitory and bactericidal activity of lactose esters towards Gram-positive bacteria. 285 
Lactose esters containing decanoate and laurate were more microbial inhibitory than esters 286 
containing octanoate and myristate.  No esters inhibited the growth of the Gram-negative 287 
bacteria E. coli O157:H7.  The solvent used to dissolve the esters influenced the microbial 288 
inhibitory activity for some bacteria.  Ethanol (>7.5%) and DMSO (<8%) inhibited the growth of 289 
L. monocytogenes and S. suis respectively.  Additional research on the microbial inhibitory 290 
activity of these esters in food systems without the need to prior dissolve in either ethanol or 291 
DMSO is needed. 292 
 293 
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 344 
Table 1. Microorganisms and growth media used in this study 345 
Microorganism ATCC 
no./serovar 
Gram 
reactiona 
Growth 
medium 
Bacillus cereus 13061 + BHI 
Mycobacterium sp. strain KMS NA + LB 
Streptococcus suis 89/1591 + BHI 
Listeria monocytogenes EGDe + BHI 
Listeria monocytogenes FSL J1-177 + BHI 
Listeria monocytogenes FSL N3-013 + BHI 
Listeria monocytogenes FSL R2-499 + BHI 
Listeria monocytogenes FSL N1-227 + BHI 
Enterococcus faecalis V538 + BHI 
Streptococcus mutans FSL R2-499 + BHI 
Escherichia coli O157:H7 EDL 931 - LB 
a +, positive; -, negative 346 
NA = not available 347 
 348 
 349 
 350 
 351 
 352 
 353 
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Table 2. Minimum inhibitory concentrations of lactose esters as both mg/ml and mM 355 
concentrations. Esters were tested at concentrations up to 5 mg/ml. 356 
 LMO 
DMSO 
LMD 
DMSO 
LMD 
ETOH 
LML 
DMSO  
LML  
ETOH 
LMM 
DMSO 
B. cereus <5 mg/ml 
<10.7 mM 
<3 mg/ml 
<6.0 mM 
<3 mg/ml 
<6.0 mM 
<1 mg/ml 
<1.9 mM 
<1 mg/ml 
<1.9 mM 
<1 mg/ml 
<1.8 mM 
M. KMS No <1 mg/ml 
<2.0 mM 
X1 
 
<1 mg/ml 
<1.9 mM 
<0.05 mg/ml2 
<0.095 mM 
<5 mg/ml 
<9.0 mM 
S. suis <3 mg/ml 
<6.4 mM 
<3 mg/ml 
<6.0 mM 
<5 mg/ml 
<10.1 mM 
<1 mg/ml 
<1.9 mM 
<1 mg/ml 
<1.9 mM 
<3 mg/ml 
<5.4 mM 
L. 
monocytogenes 
<3 mg/ml 
<6.4 mM 
No <3 mg/ml 
<6.0 mM 
<3 mg/ml 
<5.7 mM 
<0.1 mg/ml2 
<0.19 mM 
No 
E. faecalis No No <5 mg/ml 
<10.1 mM 
<5 mg/ml 
<9.5 mM 
<1 mg/ml 
<1.9 mM 
No 
S. mutans No No No <1 mg/ml 
<1.9 mM 
<3 mg/ml 
<5.7 mM 
No 
X1 = no growth in treatment or control at 5 mg/ml 357 
2Data obtained from Wagh et al., 2012. 358 
No = No growth inhibition 359 
 360 
 361 
 362 
 363 
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Table 3. Minimum bactericidal concentration of lactose esters as both mg/ml and mM 365 
concentrations. Esters were tested at concentrations up to 5 mg/ml. The log reductions of the 366 
treatment samples compared to the controls are given as log values. 367 
 LMO 
DMSO  
LMD 
DMSO  
LMD 
ETOH 
LML 
DMSO  
LML 
ETOH 
LMM 
DMSO 
B. cereus <5 mg/ml 
<10.7 mM 
7 log 
<3 mg/ml 
<6.0 mM 
9 log 
<5 mg/ml 
<10.1 mM 
7 log 
<1 mg/ml 
<1.9 mM 
7 log 
<5 mg/ml 
>9.5 mM 
8 log 
<3 mg/ml 
<5.4 mM 
8 log 
M. KMS No <1 mg/ml 
<2.0 mM 
8 log 
X1 <1 mg/ml 
<1.9 mM 
7 log 
<1 mg/ml2 
<1.9 mM 
4 log 
<5 mg/ml 
<9.0 mM 
8 log 
S. suis X1 <3 mg/ml 
<6.0 mM 
7 log 
<5 mg/ml 
<10.1 
5 log 
<1 mg/ml 
<1.9 mM 
7 log 
<5 mg/ml 
<9.5 mM 
8 log 
<5 mg/ml 
<9.0 mM 
2 log 
L. 
monocytogenes 
No No <3 mg/ml 
<6.0 mM 
6 log 
<5 mg/ml 
<9.5 mM 
8 log 
<5 mg/ml2 
<1.9 mM 
5 log 
No 
E. faecalis No No <5 mg/ml 
<10.1 mM 
4 log 
No No No 
S. mutans No No No No No No 
X1 = no growth in treatment or control at 5 mg/ml 368 
2Data obtained from Wagh et al., 2012. 369 
No = No MBC value 370 
